Emergent BioSolutions | EBS - Stock

Stock Price
10.93
Daily Change
-0.06 -0.55%
Monthly
-4.96%
Yearly
41.76%
Q1 Forecast
10.65

Emergent BioSolutions reported $328.9M in Stock for its fiscal quarter ending in December of 2023.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Akebia Therapeutics USD 18.64M 1.93M Sep/2025
ALKERMES USD 191M 927K Sep/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amarin USD 184.7M 13.46M Sep/2025
ANI Pharmaceuticals USD 146.48M 8.16M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Coherus Biosciences USD 2.05M 2.46M Sep/2025
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Exact Sciences USD 166.2M 1.42M Dec/2025
Exelixis USD 27.4M 3.92M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Lexicon Pharmaceuticals USD 168K 33K Jun/2025
Lonza CHF 1.68B 163M Dec/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Myriad Genetics USD 31.6M 2.9M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Neurocrine Biosciences USD 69M 300K Dec/2025
Pacira USD 157.68M 9.52M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025